Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis by Hoffmann, Markus H et al.
RESEARCH ARTICLE Open Access
Gait changes precede overt arthritis and strongly
correlate with symptoms and histopathological
events in pristane-induced arthritis
Markus H Hoffmann
1*, Rudolf Hopf
2, Birgit Niederreiter
1, Heinz Redl
2, Josef S Smolen
1, Günter Steiner
1
Abstract
Introduction: Pristane-induced arthritis (PIA) in the rat has been described as an animal model of inflammatory
arthritis which exhibits features similar to rheumatoid arthritis in humans, such as a chronic, destructive, and
symmetrical involvement of peripheral joints. However, so far little is known about the earliest inflammatory events
and their influence on locomotor behaviour during the course of PIA. To investigate this issue a detailed analysis of
the pathologic changes occurring during the prodromal and early stages of PIA was performed.
Methods: Arthritis was induced in DA.rats by injection of 150 μl 2,6,10,4-tetramethyl-pentadecane (pristane) at the
base of the tail and changes in locomotor behaviour of the affected paws were monitored using the CatWalk
quantitative gait analysis system. The pathologic events occurring in the joints of pristane-injected animals were
studied before onset, at onset, and during acute phase of arthritis by histological methods.
Results: Gait analysis revealed that changes in locomotion such as reduced paw print areas and stance phase time
are already apparent before the onset of clinically discernible arthritis symptoms (erythema, paw swelling) and
correlate with PIA scores. In agreement with these findings, inflammatory tenosynovitis could be observed by
histology already before the onset of erythema and swelling of the respective paws. In the most heavily affected
rats also irregularities in step sequence patterns occurred A kinetic analysis of clinical and histological findings
demonstrated that gait changes precede the pathological changes occurring during the acute phase of pristane-
induced arthritis.
Conclusions: Gait analysis allows for pinpointing the initial inflammatory changes in experimental arthritis models
such as pristane-induced arthritis. Analysis of early clinically relevant symptoms in arthritis models may facilitate the
search for novel therapeutics to interfere with pain, inflammation and joint destruction in patients suffering from
inflammatory arthritis.
Introduction
Arthritis is a clinical entity characterized by joint swelling,
stiffness and spontaneous or motion-related pain. Impair-
ment of physical function, that is, disability, is the major
complication of arthritis and the degree of its reversibility
depends on both our potential to interfere with the active
disease process as well as with joint damage, given that the
latter is currently not reversible [1].
Our current knowledge on the pathogenesis of chronic
inflammatory joint diseases such as rheumatoid arthritis
(RA) is still limited. While evidently there are a variety
of important genetic factors involved [2] and a large
proportion of patients develops autoantibodies consis-
tent with the involvement of an autoimmune response,
neither the trigger(s) of disease are known nor are the
pathways leading to chronicity fully understood. There-
fore, animal models of arthritis are very useful in dis-
secting these pathways, although each of them may
depict only a facet of RA or other forms of inflamma-
tory joint disease. To a large extent these models rely
on the assessment of disease activity, which is hampered
by the inability to obtain subjective symptomatological
information and, therefore, is at best semi-quantitative
in nature. Also, since physical function, the most
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assessed by questionnaires [3], disability cannot be eval-
uated in a similar way in experimental animal models.
Therefore, tools which could address disability to allow
comparison between different models or allow us to
improve our understanding of the effects of therapeutic
interventions would be highly valuable.
I nt h ep r e s e n ts t u d yw eh a v ec h a r a c t e r i z e dt h ee f f e c t s
of varying degrees of severity of pristane-induced arthri-
tis (PIA) in rats on physical function using the CatWalk
method. Arthritis can be induced in susceptible rat
strains such as Dark Agouti (DA) or Lewis by a single
intradermal injection of the chemically inert mineral oil
pristane. The induced disease closely mimics human RA
as it fulfils many of the clinical criteria of RA including
a symmetrical involvement of peripheral joints, the pre-
sence of rheumatoid factor and anti-RA33 antibodies
[4], destruction of cartilage and bone, and a chronic dis-
ease course [5]. Arthritis in the DA rat develops sud-
denly and dramatically around two weeks after pristane-
injection. An episode of severe and destructive arthritis
in the peripheral joints follows and gradually subsides
several weeks later. Subsequently, a chronic relapsing
disease develops in most of the animals which can reach
almost as high a severity as during the first arthritic epi-
sode and does not subside [6].
The CatWalk-system was originally developed for
studying rats with spinal cord injuries [7], and is a
v i d e o - b a s e ds y s t e mf o ra u t o m a t e dg a i ta n a l y s i st h a t
enables to measure a number of variables pertaining to
gait pattern and weight-bearing. CatWalk has recently
been used to assess gait changes caused by carrageenan-
induced arthritis [8,9] and adjuvant-induced arthritis
[10]. Similar systems employing a treadmill instead of a
flat surface for walking were applied for characterizing
adjuvant arthritis in the rat and collagen-induced arthri-
tis in the mouse [11,12]. Furthermore, thermal imaging
of paws can provide reliable information about the
degree of joint inflammation in murine and rat models
of arthritis [13,14].
In the present study arthritic rats were followed from
the preclinical and early stages of arthritis, over the maxi-
mum severity to the remission after the acute phase of
PIA. It will be shown that severe arthritis dramatically
affects the walking pattern and thus physical function in
this experimental model. Importantly, since gait changes
are detectable already before the onset of clinically visible
symptoms of arthritis such as erythema and swelling,
automated locomotor analysis may be of particular inter-
est to define the earliest processes involved in a very
severe and debilitating disease such as PIA.
Materials and methods
Animals
Dark Agouti (DA) rats (originating from Zentralinstitut
für Versuchstierzucht, Hannover, Germany) were bred
and maintained under Specific Pathogen Free (SPF)
conditions in the animal facility of the Institute of Bio-
medical research, Medical University of Vienna, Aus-
tria. Rats were housed in groups of two to three in
plastic cages with 12 h light/dark-cycles. Standard
rodent chow and water was provided ad libitum.
Experiments were performed on age- and sex-matched
animals. All experiments were approved by the local
ethical committee.
Induction and evaluation of pristane-induced arthritis
Arthritis was induced in rats at the age of 8 to 12 wk
by a single intradermal injection at the base of the tail
with 150 μl of pristane oil (2,6,10,4-tetramethylpenta-
decane; Sigma-Aldrich, St. Louis, USA). Control rats
received intradermal injection of sterile phosphate-buf-
fered saline (PBS; PAA Laboratories, Pasching, Aus-
tria). Rats were randomly allocated to pristane- or
PBS-groups. Arthritis development was monitored by a
blinded observer in all four limbs using a semiquanti-
tative scoring system as previously described [15].
Briefly, one point was given for each swollen or red
finger/toe (erythema or swelling of distal or proximal
interphalangeal joint or both), one point was given for
each swollen or red metacarpophalangeal/meta-tarso-
pahalangeal joint, and one to five points were given for
a swollen wrist/ankle, depending on severity (the maxi-
mum score per limb and rat was 15 and 60, respec-
tively). The rats were scored at days 0, 6, 9, 11, 12, 14,
16, 19, 24, 29 and 35 after injection.
Assessment of pain- and arthritis-induced gait changes
with the CatWalk method
The CatWalk system (Noldus Information Technology,
Wageningen, The Netherlands) has been described in
detail elsewhere [7]. In short, it is a video-based system
for automated gait analysis using an enclosed walkway
with a glass floor where light enters along one long
edge. At the placement of a paw, the light projected
into the glass floor is scattered and produces an illumi-
nated print. Using this method it is possible to measure
a number of gait and weight bearing-variables. To avoid
possible misinterpretation, the analysis was performed
using a threshold value for skin-floor contact of 44 arbi-
trary units (a.u, possible range 0 to 255), that is, all pix-
els brighter than 44 were used.
In this study the following variables were analysed:
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The total floor area contacted by the paw during
stance phase, that is, the area that would be black-
ened if the animal’s paw had been painted with ink.
2. Duration of stance phase:
Since the absolute duration of stance or swing phase
depends on the animal’s walking speed, these vari-
ables are transformed to a fraction of total step
duration according to the following formula: fraction
stance phase = stance phase duration/(stance phase
duration + swing phase duration), where the stance
phase duration is the time of contact of one paw
with the floor during a single stepcycle and the
swing phase duration is the time of non-contact
with the floor during the stepcycle.
3. Regularity index:
Interlimb coordination is complete if only normal
step sequence patterns occur during uninterrupted
locomotion (that is, when the animal places the four
paws one after another). The regularity index grades
the degree of interlimb coordination as follows: RI =
(NSSP × 4/PP) × 100 (%) wherein NSSP represents
the number of Normal Step Sequence Patterns and
PP the total number of Paw Placements. In healthy
animals this value is 100%.
Testing was performed between 09:00 and 16:00 h on
age-matched DA. 1F rats. All animals were first allowed
to habituate in and to cross the walkway before record-
ing of runs. Testing was conducted by the same person.
At each test occasion the animals were allowed to walk
until a satisfactory recording was acquired. A satisfac-
tory recording was defined as uninterrupted locomotion
for a sufficiently long distance of the walkway to get at
least three to four paw-placements by each non-arthritic
paw. If the animal stopped to explore the environment
by rearing, turned around to walk in the opposite direc-
tion or if it refused to walk far enough, the recording
was repeated. A >5% reduction of print area or shorten-
ing of stance phase time versus pre-operative values was
considered a significant change in locomotor behaviour.
Histological examinations
Paws from rats 11 and 35 days after injection of pristane
or PBS were collected and decalcified with ethylenedia-
minetetraacetic acid (EDTA). Serial paraffin-embedded
tissue sections of hind and front paws were analysed by
H&E staining, by tartrate-resistant acid phosphatase
(TRAP) staining (leukocyte acid phosphatase kit; Sigma-
Aldrich) for the identification of osteoclasts, and by
toluidine blue staining for visualizing cartilage. Areas of
synovial inflammation, erosions of cartilage and bone,
and number of osteoclasts were determined by
histomorphometry using an Axioskop 2 microscope
(Zeiss, Oberkochen, Germany) and the OsteoMeasure
analysis software (Osteometrics, Decatur, GA, USA).
Statistical analysis
For each walk of an animal, the mean was calculated per
paw for print area, stance and swing duration. Regularity
index was also obtained. Mean values for all variables
were then calculated for pristane- and PBS-injected rats.
Comparisons between gait variables in control and pris-
tane groups were made by ANOVA tests. Where signifi-
cant effects were found, subsequent comparisons were
performed using Dunnett’s test. Comparisons with pre-
morbid values within groups (gait variables, arthritis
scores, and histological assessments) were statistically
tested using paired t-tests. To analyse correlations
between arthritis score area under the curve (AUC) and
area under the curve of gait variables, Pearson’sc o r r e l a -
tion coefficients were calculated. All data are expressed
as mean ± Standard error of the mean (SEM).
Results
Analysis of pristane-induced gait changes by CatWalk
PBS-injected (control) rats did not develop arthritis and
print area and stance phase remained constant over the
analysed period of time (Figure 1). In these animals dur-
ing uninterrupted locomotion only complete step cycles
were performed. Interestingly, in the rats tested there
was a significant difference in print area between front
and hind paws, with front paws covering a larger area
(149.30 ± 0.66 mm
2 vs 96.67 ± 0.73 mm
2, P < 0.0001,
Figure 1A, C). Furthermore, the fraction of the stance
phase duration relative to the total step duration was
significantly longer for hind legs compared to front legs
(0.747 ± 0.004 vs 0.593 ± 0.003, P < 0.0001, Figure 1B,
D). In contrast, no significant differences were observed
at any time over the test period between the left and
right sides for print area and stance phase time.
Figure 2 shows the influence of arthritis on print area
and stance phase in the individual paws of a pristane-
injected rat. Arthritis started at Day 11 after pristane-
injection in the right hind paw and at Day 12 in two
other paws; its occurrence was mirrored by a dramatic
decrease in print area of the affected paws (Figure 2A).
At the peak of the acute phase on Day 24 the print area
of the most severely affected left hind paw was reduced
to less than 10% of its pre-morbid value (Figure 2A, C).
Also the stance phase duration was heavily affected by
arthritis, although only two of three arthritic paws
exhibited a shortening of the stance-phase (Figure 2B).
This can be interpreted by the rat’sc o m p r o m i s e
between a minimization of pain and the maintenance of
functional walking. The illustrations of the CatWalk foot
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Page 3 of 10Figure 1 Gait analysis by CatWalk in a healthy rat.T i m ec o u r s eo ft h ep r i n ta r e a(A) and the duration of stance phase measured as the
fraction of total step duration (B) of all four paws in a 10-week-old female control rat walking across the CatWalk walkway. Front paws are
shown with filled symbols, hind paws with open symbols. Extremities of the right side are indicated as squares, of the left side as circles. Gait
variables are depicted in black, arthritis scores in red. (C) Picture of CatWalk footprints on Day 24 after injection of PBS. Prints of the left paws of
the rat are shown in red, and prints of the right paws are shown in blue. Prints of front paws are depicted in lighter colour, whereas prints of
the hind paws are darker. (D) Picture of the CatWalk gait diagram 24 days after PBS-injection. Indicated are the paw-floor contacts for each of
the paws over time. The length of each bar represents the duration of the stance phase for that particular paw. The space between bars
represents the duration of the swing phase. No conspicuous changes in gait variables were detected.
Figure 2 Gait analysis by CatWalk in an arthritic rat. Time course of the print area (A) and the duration of stance phase measured as the
fraction of total step duration (B) of all four paws in a nine-week-old female pristane-treated rat walking across the CatWalk walkway. Front
paws are shown with filled symbols, hind paws with open symbols. The left side is shown with circles, the right side with squares. Gait
parameters are depicted in black, arthritis score in red. (C) Picture of CatWalk footprints on Day 24 after injection of 150 μl pristane oil. Prints of
the left paws of the rat are shown in red, and prints of the right paws are shown in blue. Prints of front paws are depicted in lighter colour,
whereas prints of the hind paws are darker. (D) Picture of the CatWalk gait diagram 24 days after pristane-injection. Indicated are the paw-floor
contacts for each of the paws over time. The length of each bar represents the duration of the stance phase for that particular paw. The space
between bars represents the duration of the swing phase. Decreases in print area as well as in the stance phase in the arthritic paws are
observed (arrows).
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Page 4 of 10prints reveal that on Day 24 the most heavily affected
paw is not used during some of the step cycles (Figure
2C, D). With the gradual remission of arthritis from
Week 4, gait parameters were partially restored to their
pre-morbidity values (Figure 2A, B).
Gait changes mirror the clinical course of PIA and reflect
histopathological events in the joints
Untreated rats that walk across the walkway perform a
regular pattern of locomotion, placing the paws one
after another. The time normal control rats used for
crossing a 90 cm distance was about 1.52 ± 0.039 s
(velocity about 59.21 cm/s or 2.13 km/h), whereas rats
with arthritis crossed the walkway more slowly, with
mean velocity significantly decreasing to about 30.96
cm/s (1.11 km/h) (P < 0.0001).
The print areas of arthritic paws in pristane-injected
rats were significantly smaller than print areas of unaf-
fected paws and paws from PBS-injected control animals
from Day 12 until the end of the observation time at
Day 35, although they gradually came closer to control
values towards the end of the observation (Figure 3A).
Equally, the time of contact with the floor was signifi-
cantly decreased in arthritic paws from Days 12 to 35,
but was gradually approaching control values after Day
24 (Figure 3B). Interestingly, both the print area and the
stance phase of non-arthritic paws from pristane-
injected animals were markedly increased when com-
pared with paws from control animals, suggesting a
transposition of weight bearing from the arthritic to the
non-arthritic limb. A second independent experiment
achieved comparable results, showing significant reduc-
tion of print area and stance phase from Day 11 in
affected paws with a concomitant increase in non-
affected paws from pristane-injected animals (data not
shown).
Effects on interlimb coordination by PIA are measured
by the CatWalk method as a decrease in % Regularity
Index (RI) (Figure 3C). Healthy, fully coordinated ani-
mals show only normal step sequences (RI = 100%), but
in arthritic rats that exhibited loss of paw placements of
affected paws, the RI decreased in parallel with the
increasing severity of arthritis. With the remission of
inflammation in the paw, the affected paws could be
used normally again and RI returned towards normal
values.
When comparing clinical arthritis scores with
changes in gait, we found highly significant correlations
(r = -089 and r = -0.91, respectively, P < 0.0001, Figure
4A, B). A systematic kinetic analysis comparing the clin-
ical, histological and CatWalk findings at characteristic
time point showed that the degree of inflammation, the
number of osteoclasts and the observed gait changes
mirrored the clinical course of PIA, showing the highest
values in the acute phase, where also arthritis scores
were highest (Figure 4C). Interestingly, early inflamma-
tory infiltrates and gait changes (reduction of print area
and stance phase shortening), but not osteoclasts or ero-
sions could be observed prior to onset of clinically visi-
ble arthritis.
Gait analysis detects changes prior to the onset of clinical
symptoms of arthritis and can thus be used to precisely
spot the timing of histological assessment of the earliest
phase of PIA
Analyses of the early changes revealed that gait changes
occurred significantly earlier than the onset of clinical
arthritis symptoms. Figure 5 shows the full disease
course in a representative paw from injection of pristane
to full-blown inflammation during the acute phase of
PIA. Whereas there are detectable gait changes already
at Day 11 (6.23% shortening of stance phase and 5.04%
reduction of print area compared to Day 0, respectively,
Figure 5A), no external clinical symptoms of arthritis
can be seen yet (Figure 5B). With the beginning of
externally visible arthritis at Day 12 print area and
stance phase are further reduced.
On average, the first clinical symptoms became dis-
cernible 12.68 ± 0.36 days after pristane-injection, while
print area reduction was seen already from 11.60 ± 0.48
days after pristane-injection (1.05 ± 0.54 days before the
clinical appearance of arthritis), and the mean onset of
stance phase shortening was 11.35 ± 0.49 days after
pristane-injection, that is, 1.20 ± 0.71 days before the
onset of clinical changes (Figure 5C). Thus, gait changes
assessed by CatWalk precede the onset of clinically
apparent pristane-induced arthritis.
To determine the nature of the initial events occurring
in the joint shortly before the onset of clinically appar-
ent arthritis, three pristane-injected rats were analysed
by CatWalk and sacrificed when conspicuous changes in
gait variables were detected (Figure 6A). Histological
analysis revealed that at the time of beginning gait
changes signs of inflammation were already discernible
in the joint. Inflammatory infiltrates could be detected
at both the tendon sheaths and the synovium (Figure
6B, C). However, osteoclasts as detectable by TRAP
staining were not yet seen and toluidine blue staining
hardly revealed any proteoglycan loss of the articular
cartilage at this early stage of disease (not shown).
Discussion
Recognition of early arthritis is one of the most impor-
tant aspects in rheumatology, since it allows interference
with the disease process before massive damage has
occurred. On the other hand, information on the char-
acter of the initial pathologic events is limited, since the
affected structures are not directly accessible in patients
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Page 5 of 10Figure 3 Longitudinal gait analysis of pristane-induced arthritis. Time course of the print area (A) and the stance phase-fraction of total
step duration (B) of paws of pristane-injected versus control rats. Mean values obtained for the gait variables of affected (n = 16) and
unaffected (n = 8) paws are shown in black. Respective values of all paws of pristane-injected animals (n = 24) are also depicted for comparison.
Arthritis scores of affected paws are depicted in red. Mean values ± SEM of paws were calculated and subjected to ANOVA with Dunnett’s post
hoc test to compare paws of pristane-injected animals with paws of control animals. * P < 0.05, ** P < 0.01. For longitudinal analysis within each
group, locomotion and arthritis score was recorded prior to injection and was used as the baseline reading (Day 0). Comparisons with later time
points were performed using paired t-tests. + P < 0.05, ++ P < 0.01, +++ P < 0.001. One representative out of two experiments is shown (C)
Time course of the regularity index measured by the percentage of normal step sequence patterns in naive control rats (n = 8) and rats injected
with pristane (n = 12). Overall arthritis scores of affected animals are depicted in red. The curves show mean values ± SEM. Differences to pre-
morbid values were calculated using paired t-tests.
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Page 6 of 10with very early disease and imaging techniques such as
magnetic resonance imaging or sonography do not pro-
vide insights into the cellular processes involved. There-
fore, animal models are very useful to dissect the very
early arthritic processes in the joint. Pristane-induced
arthritis (PIA) in the rat very closely mimics human RA
since it fulfils many of its clinical criteria. However, PIA
and other inducible animal models of arthritis have a
rapid disease onset and progress quickly, making the
dissection of initial phases of arthritis difficult. Indeed,
once signs and symptoms of arthritis become discern-
ible, not only full blown inflammation but also destruc-
tive events are likely to have already occurred [16,17].
This has been analysed by performing serial histological
examinations in animals that will develop arthritis
before the onset of the symptoms. However, it is diffi-
cult to envisage performing serial pre-emptive analyses
in a consistent manner and, therefore, other means have
to be sought. Thermal imaging was able to detect
inflammatory changes already prior to onset of joint
swelling in murine collagen-induced arthritis but not in
r a tP I A[ 1 3 , 1 4 ] .I nt h ep r e s e n ts t u d yw eh a v es h o w n
that the onset of inflammation in PIA is mirrored by
changes in the animals’ gait behaviour as detected by
semi-automated locomotor analysis several days before
clinically discernible signs and symptoms are apparent.
In a recent study of adjuvant-induced arthritis the
experiments were terminated before the arthritic con-
dition had become advanced [10]. The current study
also provides insight into processes of remission of
arthritis and their consequences for locomotion.
Arthritis caused by injection of pristane caused a
change in several variables typical of the way rats walk,
indicating an unwillingness or inability to use the
affected paws. The area touching the floor of the
affected paws decreased markedly, and so did the time
they rested on the floor. This was apparent about 11
to 12 days after pristane-injection, with maximum
effects observed around Days 20 to 24 after pristane-
injection and then gradually returning towards control
Figure 4 Clinical variables and histopathological changes of PIA correlate with gait changes measured by CatWalk. X-Y scatter plots of
correlations between arthritis score AUC and print area AUC (A) and stance-phase fraction of total step duration AUC (B) of individual paws (n
= 80) from pristane-injected and control animals are shown. Pearson coefficients (r) and P-values are depicted within the graph. (C) Rats were
monitored by CatWalk and sacrificed at characteristic time points (Day 0 = naïve animals, Day 11 = preclinical phase, Day 14 = onset, Day 20 =
highest severity, Day 35 = begin of remission). The areas of inflammation, erosion, and the numbers of osteoclasts were determined
histomorphometrically and adjusted to the total area of tissue analysed. The course of clinically apparent PIA is shown as an overlay in red. Each
bar represents mean ± SEM from three arthritic paws.
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Page 7 of 10values. Depending on their type, abnormalities as
revealed by the CatWalk system in heavily arthritic
paws were seen 0.9 to 4.3 days before clinically dis-
cernible signs of arthritis. Importantly, however, histo-
logical examination revealed that already at that time
and before onset of clinically apparent arthritis signifi-
cant inflammatory changes occurred in the synovial
membrane, supporting previous notions on an inflam-
matory pre-clinical phase of arthritis [18,19].
Interestingly, in line with observations in the pre-
arthritic phase of Tumor necrosis factor (TNF) a trans-
genic mice [16], in pre-clinical PIA there was not only
inflammation of the synovial membrane, but particularly
prominent inflammation of the tendon sheaths. Thus,
these data suggest that periarticular tendonitis is per-
haps the earliest event occurring in this model of RA.
It is assumed that the behavioural changes detected by
the CatWalk system in the very early phase of arthritis
Figure 5 Gait changes occur before visible arthritis is apparent. (A) Time course of the print area and the duration of stance phase
measured as the fraction of total step duration of a representative left hind paw after pristane-injection. (B) Photographic images of the left
hind paw at characteristic time points (before pristane injection = Day 0, clinically unaffected joint showing gait changes = Day 11, onset of
clinical PIA = Day 12, full-blown acute PIA = Day 16). Arrows show location of erythema and swelling on Day 12 and Day 16. (C) Comparison of
day of onset of significant gait changes (defined by >5% reduction of print area or shortening of stance phase time versus pre-operative values)
versus clinically apparent arthritis in paws with severe arthritis (arthritis score ≥5) reveals that print area reduction and stance phase shortening
occur significantly before onset of apparent PIA. Data are presented as box plots. Lines within the boxes represent the median, boxes represent
the 25
th and 50
th percentiles, and lines outside the boxes show the minimum and maximum values.
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Page 8 of 10are due to nociception, that is, detection of noxious sti-
muli and the subsequent transmission of encoded infor-
mation to the brain [20] rather than due to physical
impairment caused by swelling and destructive events
within the joint. Pain is a perceptual process that arises
in response to nociception. Although rats may not pro-
cess nociceptive stimuli in the same way humans do,
information gained from analysis using the CatWalk sys-
t e ms u g g e s t st h a tP I Ai nt h er a tc a nb eu s e dt om o d e l
pain in humans with inflammatory joint disease. Our
data suggest that inflammation-induced noxious stimuli
arise earlier than clinically visible symptoms of arthritis.
As pain on motion is a major aspect of complaint in
arthritic patients [21-23] elucidation of the processes
involved in the initial phases of arthritis which may dif-
fer from those in later stages is essential [24]. Therefore,
measuring the early clinically relevant symptoms in
arthritis models may allow searching for novel therapeu-
tics to interfere not only with pain, but particularly with
the earliest events of inflammation and subsequent joint
destruction and to improve physical function and quality
of life of patients with RA.
Figure 6 Analysis of initial pre-clinical changes in PIA. A female 10-week-old rat was injected with pristane and monitored by CatWalk. When
gait changes suggestive of a beginning onset of PIA were detected at Day 11 (A), the rat was sacrificed. At this time no clinically visible signs of
arthritis such as erythema or swelling were noticed. (B) Hematoxylin and eosin-stained paw sections of the pristane-injected rat’s hind paws and
of a PBS-injected control rat were assessed for signs of inflammation. The very early pristane-induced arthritis is characterized by synovitis and
inflammation of the tendon sheaths. Boxes in (B) are shown at 10 × magnification in (C).
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Using the PIA rat model of inflammatory polyarthritis we
show that gait changes in affected paws observed by the
CatWalk system, such as reduction of print area and
shortening of the stance phase, precede the onset of clini-
cally discernible arthritis symptoms and mirror histo-
pathological changes during the course of PIA.
Implementation of this technique in PIA reveals a begin-
ning tenosynovitis in animals with changes in locomotive
behaviour but without externally visible arthritis symp-
toms. Gait analysis can thus be used to pinpoint the exact
timing for histological assessment of the initial inflamma-
tory changes in animal models of inflammatory arthritis
and also allows for comparing disease course and gait
changes in different models in an objective manner.
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